164 filings
6-K
GLMD
Galmed Pharmaceuticals Ltd
19 Mar 24
Current report (foreign)
4:30pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
15 Mar 24
Current report (foreign)
9:13am
6-K
GLMD
Galmed Pharmaceuticals Ltd
22 Nov 23
Current report (foreign)
4:05pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
20 Nov 23
Galmed Announces a delay in the initiation of its Primary Sclerosing Cholangitis (PSC) Phase 2a Study
4:37pm
6-K
GLMD
Galmed Pharmaceuticals Ltd
26 Sep 23
Galmed Announces Allowance of New Patent for Aramchol for the Treatment of Pulmonary and Dermal Fibrosis
8:51am
6-K
40szhnn
22 Sep 23
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification
4:15pm
6-K/A
g2q0ybg t0gsh
21 Sep 23
Current report (foreign) (amended)
7:30am
6-K
1fn lbkl0b13m4rr7
20 Sep 23
Current report (foreign)
4:30pm
6-K
xj1hk0
13 Sep 23
Current report (foreign)
4:01pm
6-K
ehbyz6t k2e
9 Aug 23
Current report (foreign)
4:43pm
6-K
x14qkm5f qtdpzn
9 Aug 23
Current report (foreign)
4:30pm
6-K
34439sa2r3
2 Aug 23
Consolidated Financial Statements
4:30pm
6-K
p32r44a ks
18 Jul 23
Current report (foreign)
9:25am
6-K
jf80rcb
14 Jul 23
Galmed Pharmaceuticals Announces Pricing of $7 Million Public Offering
9:44am
6-K
mccd7bz6uzdz95vf
10 Jul 23
Current report (foreign)
8:10am
6-K
tswgourf3
1 Jun 23
Galmed Pharmaceuticals Reports First Quarter 2023 Financial Results
8:14am
6-K
8pprea0nnawz9e7
12 May 23
Current report (foreign)
7:00am
6-K
fabiz
11 May 23
Current report (foreign)
4:15pm
6-K
d7w 7zwlomsu
9 May 23
Current report (foreign)
7:14am
6-K
nwu awmqu131
4 May 23
Current report (foreign)
4:15pm